In-thrombus thrombin secretion: a new diagnostic marker of atrial fibrillation in cryptogenic stroke

Ze'ev Itsekson Hayosh, Eiman Abu Bandora, Natalia Shelestovich, Maya Nulman, Mati Bakon, Gal Yaniv, Boris Khaitovitch, Shmuel Balan, Alexandra Gerasimova, Tali Drori, Stefan Mausbach, Yvonne Schwammenthal, Arnon Afek, Joab Chapman, Efrat Shavit Stein, David Orion

Research output: Contribution to journalArticlepeer-review

Abstract

Endovascularly retrieved clots may be a potential resource for diagnosing stroke etiology. This method may influence secondary prevention treatment. We measure thrombin activity eluted by serially washing clots. We concluded that an assay measuring the change in thrombin in clots retrieved during acute stroke endovascular thrombectomy procedures may serve as a diagnostic marker of the origin of the clot. The suggested mechanism for these differences may be the clot location before its retrieval, with high blood flow causing thrombin washout in atherosclerotic clots, in contrast to atrium appendage low blood flow retaining high thrombin levels.

Original languageEnglish
Pages (from-to)853-854
Number of pages2
JournalIsrael Medical Association Journal
Volume25
Issue number12
StatePublished - 1 Dec 2022

Fingerprint

Dive into the research topics of 'In-thrombus thrombin secretion: a new diagnostic marker of atrial fibrillation in cryptogenic stroke'. Together they form a unique fingerprint.

Cite this